Related Experiment Videos
Tumor angiogenesis in vulvar squamous cell carcinoma
F Qureshi1, A Munkarah, M Banerjee
1Department of Pathology, Hutzel Hospital and Wayne State University School of Medicine, Detroit, Michigan, 48201, USA.
Gynecologic Oncology
|January 16, 1999
Summary
Tumor angiogenesis, the growth of new blood vessels, does not predict outcomes in invasive vulvar squamous cell carcinoma. Microvessel density did not correlate with cancer stage, survival, or invasion patterns in this study.
Area of Science:
- Oncology
- Pathology
- Cancer Research
Background:
- Angiogenesis is linked to metastasis in some cancers.
- Its role in invasive vulvar squamous cell carcinoma (VSCC) is unstudied.
Purpose of the Study:
- To investigate the correlation between tumor angiogenesis and clinicopathological factors in VSCC.
- To determine if angiogenesis can serve as a prognostic indicator for VSCC.
Main Methods:
- Studied 50 cases of VSCC diagnosed between 1987-1993.
- Quantified microvessel density using Factor VIII immunohistochemistry.
- Correlated microvessel counts with tumor stage, invasion patterns, and patient survival.
Main Results:
- No significant difference in microvessel density was found between early (I/II) and late (III/IV) stage VSCC.
- Angiogenesis did not correlate with patient survival outcomes.
- Microvessel counts were similar across different invasion patterns (spray, pushing, mixed).
Conclusions:
- Tumor angiogenesis is not a significant prognostic factor in invasive vulvar squamous cell carcinoma.
- Angiogenesis markers do not reliably predict stage, survival, or invasion patterns in VSCC.